Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Induction in Sensitized Kidney Transplant Recipients Without Preexisting Donor-specific antiboDies: a Randomized Multicentre Trial Between a Lymphocyte Depleting and Basiliximab.

NCT05385432 is registered in ClinicalTrials.gov with University Hospital, Tours as lead sponsor.

NCT NCT05385432
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05385432 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Induction in Sensitized Kidney Transplant Recipients Without Preexisting Donor-specific antiboDies: a Randomized Multicentre Trial Between a Lymphocyte Depleting and Basiliximab.
Lead sponsor
University Hospital, Tours
Phase
Phase 3
Overall status
Recruiting
Start date
November 7, 2023
Completion date
December 30, 2030
Enrollment
244 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

induction therapy, renal transplant rejection